Head-To-Head: Hargreaves Lansdown plc’s New High Income Fund vs GlaxoSmithKline plc, Unilever plc And Imperial Brands plc

Does the new High Income Fund from Hargreaves Lansdown plc (LON: HL) match what’s on offer from GlaxoSmithKline plc (LON: GSK), Unilever plc (LON: ULVR) and Imperial Brands plc (LON: IMB)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

After seven years of ultra-low interest rates, investors and savers alike have seen numerous alternative methods of obtaining an acceptable yield on their savings income. Traditional, safer, savings accounts are covered up to £75k for individual accounts and £150k for joint accounts per institution. But savers seeking an acceptable return on their nest eggs have been forced to look elsewhere – even where there’s more risk.

Appealing to the ‘grey’ pound

One thing’s clear from the demographics at play in the UK and in certain other parts of the developed world, the population as a whole is living longer. I could write about the many moving parts that are at work behind the scenes. However, I’m focusing on how companies are looking to serve the opening in the market that I expect to grow significantly over the next few years as baby boomers reach retirement age and start to look for income to replace that lost from employment.

And when I received my copy of Investment Times from asset manager Hargreaves Lansdown (LSE: HL) I noticed a new Multi-Manager High Income Fund launch that appears to be positioned to tackle the lack of income on offer from banks.

The new fund will be led by Lee Guardhouse and Ellen Powley who will seek to deliver a sustainable high income, distributed on a monthly basis. Though the yield at the launch price of £1 is expected to be around an above-average 4.5%, as with all riskier investments, this is variable and not guaranteed.

In order to smooth any volatility, the fund will invest in the managers’ favourite funds that are themselves investing in both shares and corporate bonds. Initially the managers are eying a 60/40 split in favour of funds investing in shares, though obviously this could change over time in order to achieve the best result for clients as the economy ebbs and flows.

Is there a better way?

I have to say that if I were a novice investor with a lump sum to invest for regular income, I would be tempted by the Hargreaves offering. However, as with all funds, investors need to keep a watchful eye on charges, both in terms of the underlying investments of the funds within the fund, and the fund itself.

Accordingly, as a slightly more experienced investor, I tend to lean towards shares of individual companies that in my view offer income, with growth in earnings that should translate into an increased dividend as time goes by.

To that end, I’ve selected three shares which look to fit the bill:

  • GlaxoSmithKline (LSE: GSK) the global healthcare company that researches and develops pharmaceuticals, vaccines and consumer healthcare products – forward yield of 5.89%
  • Unilever (LSE: UNLR) the global consumer defensive giant engaged in the supply of food, home and personal care products – forward yield of 2.96%
  • Imperial Brands (LSE: IMB) formerly Imperial Tobacco, a global fast-moving consumer goods company focused on a tobacco portfolio that offers a range of cigarettes, fine cut and smokeless tobaccos, plus papers and cigars – forward yield of 4.29%

Taken together, these three stocks yield an above average 4.38% that I expect to grow over time, and importantly, as depicted by the chart, they’ve also outperformed the FTSE 100 over the last 12 months.

Dave Sullivan owns shares in Imperial Brands. The Motley Fool UK owns shares of and has recommended Unilever. The Motley Fool UK has recommended GlaxoSmithKline and Hargreaves Lansdown. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Aviva logo on glass meeting room door
Investing Articles

£5,000 invested in Aviva shares 6 years ago is now worth…

The last six years have been interesting for Aviva shares, to say the least. How would a few thousands pounds…

Read more »

Businessman hand stacking up arrow on wooden block cubes
Growth Shares

Why I think the HSBC share price could hit 2,000p by December

Jon Smith explains why the HSBC share price could be primed to rally for the rest of the year, despite…

Read more »

Elevated view over city of London skyline
Investing Articles

£15,000 invested in UK shares a decade ago is now worth…

How have UK shares performed in recent years? That depends which ones you have in mind, as our writer explains.…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

3 FTSE shares with many years of consecutive dividend growth

Paul Summers picks out a selection of FTSE shares that have offered passive income seekers consistency for quite a long…

Read more »

piggy bank, searching with binoculars
Investing Articles

Prediction: Diageo shares could soar in the next 5 years if this happens…

Diageo shares have been in the doldrums for some years now. What on earth could waken this FTSE 100 dud…

Read more »

Investing Articles

With a P/E of 5.9 is this a once-in-a-decade opportunity to buy dirt-cheap easyJet shares?

Today marks a fresh low for easyJet shares, which are falling on a disappointing set of first-half results. Harvey Jones…

Read more »

Investing Articles

Think the soaring Tesco share price is too good to be true? Read this…

The Tesco share price keeps climbing. It's up again today, following a positive set of results, but Harvey Jones says…

Read more »

Artillery rocket system aimed to the sky and soldiers at sunset.
Investing Articles

BAE Systems shares are up 274% in 46 months. And I reckon there could be more to come

Our writer’s been learning about the state of Britain’s defence forces. And he thinks it could be good news for…

Read more »